Insmed Inc $17.70

down -0.04


22/7/2014 04:00 PM  |  NASDAQ : INSM  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get INSM Trend Analysis - it has outperformed the S&P 500 by 30%

Partner Headlines

  1. Events Scheduled for Week of Jun 23rd to Jun 27th, 2014

    Benzinga
  2. Mid-Afternoon Market Update: Fed Tapers Another $10B; Will Purchase $15B/Month ...

    Benzinga
  3. Mid-Day Market Update: US Stocks Slide Ahead Of Fed Decision; Adobe Shares ...

    Benzinga
  4. Mid-Morning Market Update: Markets Mostly Flat; FedEx Results Top Street ...

    Benzinga
  5. Benzinga's Volume Movers

    Benzinga
  6. Morning Market Movers

    Benzinga
  7. Insmed Up Over 30% Following FDA Decision

    Benzinga
  8. Benzinga's Top #PreMarket Gainers

    Benzinga
  9. Insmed Shares Rally Over $14 As Piper Jaffray Boosts Price Target To $51

    Benzinga
  10. Mid-Afternoon Market Update: American Capital Rises as MannKind Shares ...

    Benzinga
  11. Mid-Day Market Update: Nordion Surges On Acquisition News; BlackBerry Shares ...

    Benzinga
  12. Insmed falls on mixed results

    IBD
  13. Market Wrap For March 26: Markets Close Near Session Lows In Yet Another ...

    Benzinga
  14. Insmed Falls On Mixed Results For Lung Drug

    IBD
  15. Morning Market Losers

    Benzinga
  16. Benzinga's Top #PreMarket Losers

    Benzinga
  17. UPDATE: Insmed Says Arikayce Did Not Meet Pre-Specified Level for Statistical ...

    Benzinga
  18. Benzinga's Top #PreMarket Gainers

    Benzinga
  19. Benzinga's Top #PreMarket Losers

    Benzinga
  20. UPDATE: Piper Jaffray Initiates Coverage on Insmed as 2014 Biotech Sector ...

    Benzinga
  21. Market Wrap For Tuesday, October 15: Earnings Reports And White House Progress ...

    Benzinga
  22. Mid-Afternoon Market Update: Tumi Holdings Rises Amid Market Decline

    Benzinga
  23. Insmed Reports Issuance of Two Patents

    Benzinga
  24. Leerink Swann Reiterates Outperform on Insmed Following MEDACorp KOL Checks

    Benzinga
  25. Weekly CEO Buys Highlight: TPGI, INSM, EQU, FCEL

    GuruFocus
  26. Insmed Names Lewis CEO

    Benzinga
  27. Insmed Inc. Reports Operating Results (10-Q)

    GuruFocus
  28. Insmed up 12% After Insider Share Purchase

    Benzinga
  29. Insmed Provides Corporate Update; Projects Cash Sufficient to Generate ...

    Benzinga
  30. Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical ...

    Benzinga
  31. Insmed Skyrockets 70% after FDA Lifts Clinical Hold

    Benzinga
  32. Benzinga's Microcap Movers for Friday January 20, 2012

    Benzinga
  33. Insmed Surges after Clinical Hold Lifted by FDA

    Benzinga
Trading Center